logo-loader
viewPredictmedix Inc.

Predictmedix signs with fortune 500 company Tech Mahindra to use impairment detection technology

Predictmedix (CSE: PMED-OTCQB: PMEDF) CEO Dr Rahul Kushwah joined Steve Darling from Proactive Vancouver to discuss the company signing a deal with mega company Tech Mahindra. Kushwah discusses their impairment technology and how Tech Mahindra will be utilising it going forward.

Quick facts: Predictmedix Inc.

Price: 0.94 CAD

CSE:PMED
Market: CSE
Market Cap: $94.05 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Predictmedix Inc. named herein, including the promotion by the Company of Predictmedix Inc. in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

PredictMedix files two U.S. patents for technology while seeing big growth...

PredictMedix (CSE: PMED- OTCQB: PMEDF) CEO Dr Rahul Kushwah, Thomas Loftus, Director with Taurus Medical Solutions, and Dr Arun Chauhan with Vital healthcare Group joined Steve Darling from Proactive to a number of issues. Dr Kushwah shared with Proactive that the company has filed two...

3 days, 4 hours ago

2 min read